E.E. Geduld’s CASI Pharmaceuticals CASI Stock Holding History

E.E. Geduld’s Portfolio CASI Stock Details CASI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-1,000	Closed	-$13K	–	273
2014 Q4	$13K	Sell	1,000 -1,000	-50%	-$15.7K	0.01%	223
2014 Q3	$36K	Hold	2,000	–	–	0.03%	207
2014 Q2	$36K	Sell	2,000 -500	-20%	-$9.07K	0.02%	257
2014 Q1	$46K	Buy	2,500 +1,000	+67%	+$18.9K	0.02%	254
2013 Q4	$25K	Sell	1,500 -500	-25%	-$8.46K	0.01%	282
2013 Q3	$36K	Sell	2,000 -500	-20%	-$9.5K	0.02%	252
2013 Q2	$51K	Buy	+2,500	New	+$48.5K	0.04%	223

Other funds holding CASI

WSCM

Wellington Shields Capital Management New York $788M AUM 66.95% 1-Year Est. Return

WSC

Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

Moors & Cabot Boston, Massachusetts $2.57B AUM 37.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

E.E. Geduld's CASI Position: Q1 2015 in Review

E.E. Geduld sold out of CASI Pharmaceuticals (CASI) in Q1 2015, closing a stake of 1,000 shares — an estimated $13K sold.

E.E. Geduld first reported a position in CASI in Q2 2013 and held it in 7 quarters. The position peaked at $51K in Q2 2013. 30 funds tracked by Wall St. Rank hold CASI as of Q1 2015.

E.E. Geduld reported no remaining CASI Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
E.E. Geduld sold 1,000 CASI Pharmaceuticals shares in Q1 2015, an estimated $13K.
E.E. Geduld first reported a position in CASI Pharmaceuticals in Q2 2013 and held it in 7 quarters.
E.E. Geduld's CASI Pharmaceuticals position peaked at $51K in Q2 2013.
30 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q1 2015.

Based on E.E. Geduld's 13F filing for Q1 2015, filed 1 May 2015.